17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice by Song, Chin-Hee et al.
1
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12283  | https://doi.org/10.1038/s41598-020-69112-w
www.nature.com/scientificreports
17β‑estradiol supplementation 
changes gut microbiota 
diversity in intact and colorectal 
cancer‑induced icR male mice
chin‑Hee Song1, nayoung Kim 1,2*, Ryoung Hee nam1, Soo in choi1, Ha‑na Lee3 & 
Young‑Joon Surh4
The composition of the gut microbiota is influenced by sex hormones and colorectal cancer (CRC). 
Previously, we reported that 17β-estradiol (E2) inhibits azoxymethane/dextran sulfate sodium (AOM/
DSS)-induced tumorigenesis in male mice. Here, we investigated whether the composition of the 
gut microbiota is different between male and female, and is regulated by estrogen as a secondary 
outcome of previous studies. We established four groups of mice based on the sex and estrogen 
status [ovariectomized (OVX) female and E2-treated male]. Additionally, three groups of males were 
established by treating them with AOM/DSS, and E2, after subjecting them to AOM/DSS treatment. 
The mice were sacrificed at 21 weeks old. The composition of the gut microbiota was analyzed using 
16S rRNA metagenomics sequencing. We observed a significant increase in the microbial diversity 
(Chao1 index) in females, males supplemented with E2, and males treated with AOM/DSS/E2 
compared with normal males. In normal physiological condition, sex difference and E2 treatment did 
not affect the ratio of Firmicutes/Bacteroidetes (F/B). However, in AOM/DSS-treated male mice, E2 
supplementation showed significantly lower level of the F/B ratio. The ratio of commensal bacteria 
to opportunistic pathogens was higher in females and E2-treated males compared to normal males 
and females subjected to OVX. Unexpectedly, this ratio was higher in the AOM/DSS group than that 
determined in other males and the AOM/DSS/E2 group. Our findings suggest that estrogen alters 
the gut microbiota in ICR (CrljOri:CD1) mice, particularly AOM/DSS-treated males, by decreasing the 
F/B ratio and changing Shannon and Simpson index by supply of estrogen. This highlights another 
possibility that estrogen could cause changes in the gut microbiota, thereby reducing the risk of 
developing CRC.
Colorectal cancer (CRC) is the third leading cause of cancer death in both men and women in the United States, 
with an estimation of 101,420 and 51,020 new cases of cancer and cancer-related deaths, respectively, in  20191. 
Chronic inflammation following viral or bacterial infections is considered as an important risk factor involved in 
human carcinogenesis, including CRC 2 and its association has been reported, particularly in infections such as 
viral hepatitis and hepatocellular  carcinoma3, as well as that of Helicobacter pylori and gastric  adenocarcinoma4. 
Moreover, it has been reported that opportunistic pathogens play a role in colorectal carcinogenesis. Fusobacte-
rium nucleatum, Escherichia coli, Streptococcus gallolyticus (formerly known as S. bovis), Enterococcus faecalis, and 
enterotoxigenic Bacteroides fragilis (a toxin-producing bacteria) have been considered as candidate microorgan-
isms responsible for triggering the colorectal  carcinogenesis5. Additionally, results obtained from several animal 
experiments have suggested that these bacteria could be the causative microorganisms responsible for colorectal 
 carcinogenesis5. According to a recent report, infection with F. nucleatum had promoted chemoresistance to 
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5-fluorouracil by upregulating the expression of baculoviral IAP repeat-containing 3 (BIRC3) in CRC  cells6. 
Additionally, abundance of F. nucleatum could be correlated with the chemoresistance observed in patients 
with advanced CRC 6. However, a clear cause-and-effect relationship between F. nucleatum and CRC has not 
been established.
The composition of the gut microbiota is driven by a number of factors such as diet, antibiotic therapy, mater-
nal microbiota, and genotype of the  individual7–9. Thus, conducting research on the gut microbiota of humans 
is very difficult. Instead, genetically homogenous mice housed and administered with identical controlled envi-
ronments and diets, respectively, render lesser variability in conditions. A mouse model developed by treating 
the animals with azoxymethane (AOM, a pro-carcinogenic agent) and dextran sulfate sodium (DSS, a chemical 
colitogen) is most widely used in the investigation of the molecular pathogenesis of colitis and colitis-associated 
CRC 10,11. This animal model is well established for the identification of multistep tumor progression based on the 
presence of aberrant crypt foci (ACF)-adenoma-carcinoma sequence, through which, molecular alterations are 
assessed in specific phases of the carcinogenic  process12. According to several reports, the richness and diversity 
of the composition of the gut microbiota change upon treatment with AOM and/or  DSS13–15. Particularly, in 
female C57BL/6 mice treated with 4% DSS, the relative abundance of the Lactobacillus group was lower while 
that of Enterobacteriaceae, Akkermansia and Desulfovibrio were  higher16.
It is well known that the occurrence of colorectal tumors is more frequent in men than  women17, and dif-
ferences in the incidence of CRC, which are associated with sex, exist  worldwide18. Many epidemiological data 
have suggested that the female sex hormone estrogen, exerts protective effects against CRC  development19,20. 
Therefore, in postmenopausal women, the chances of CRC incidence may increase. Indeed, CRC is considered 
as a major cause of death in elderly women above the age of 65 years in  Korea21. Interestingly, emerging evidence 
has suggested that the interaction between estrogen and gut microbiota is likely to affect the  microenvironment22 
and metabolism of the  host23. It has been revealed that the gut microbiota is regulated by estrogen, and the 
levels of estrogens are also significantly affected by gut microbiota  composition24. In animal models, bilateral 
ovariectomy (OVX) causes microbial  dysbiosis25,26. Furthermore, short-chain fatty acids (SCFA) produced by 
the gut microbiota are recognized as metabolic signaling molecules and their levels are reported to be signifi-
cantly decreased in OVX  rats26. It has been reported that, in humans, OVX is associated with an increment in 
the relative abundance of Clostridium bolteae27. In men and postmenopausal women, the levels of total urinary 
estrogens could be strongly correlated with the species richness and α-diversity of the gut  microbiota28. These 
non-ovarian systemic estrogens were positively correlated with the taxonomic abundance of Clostridia, includ-
ing non-Clostridiales, and three genera belonging to the Ruminococcaceae  family28. Additionally, alteration 
in the composition of the gut microbiota including an increase in the levels of Bifidobacteria and suppression 
of Clostridiaceae was observed in postmenopausal women upon administration of phytoestrogens such as soy 
isoflavone, which are plant-derived compounds demonstrating estrogenic  activities29.
Previously, we have reported that the severity of CRC in the AOM/DSS murine model was greater in male 
mice than female mice, as evidenced by the increased levels of inflammatory mediators such as MPO and IL-1β30. 
E2 (10 mg/kg) was found to suppress the induction of CRC by upregulating nuclear factor-erythroid 2-related fac-
tor 2 (Nrf2) in male ICR mice treated with AOM/DSS31. Furthermore, E2 treatement significantly downregulated 
the expressions of COX-2 or iNOS in TNF-α-stimulated human female normal epithelial CCD841CoN  cells32 
and mouse embryonic fibroblasts (MEFs), collectively indicating its anti-inflammatory  effect33.
Based on this, we hypothesized that sex hormones could affect the gut microbiota and subsequent devel-
opment of CRC. To evaluate this hypothesis, we focused on the microbial alterations, particularly the relative 
abundance of opportunistic pathogens, in normal or AOM/DSS-treated male mice treated with estrogen, and 
in female mice eliminated the presence of estrogen through ovariectomy, and investigated their associations 
with each other.
Results
Effect of sex and CRC on clustering and phylum compositions following supplementation with 
estrogen. The experimental groups were distinguished into two categories, which were as follows: sex and 
OVX as Group 1, and colon cancer in males as Group 2. Group 1 was further divided into 4 subgroups, which 
were as follows: normal male control mice (n = 5), E2 supplemented male mice (n = 12), normal female control 
mice (n = 11), and ovariectomized (OVX) female mice (n = 7) (Fig. 1a). Similarly, group 2 was divided into 3 
subgroups, which were as follows: normal male control mice (n = 5), AOM/DSS-treated male mice (n = 12), and 
AOM/DSS-treated male mice supplemented with E2 (n = 12) (Fig. 1b). Female mice were subjected to a sham 
surgery or ovariectomy at 4-week-old. To induce colitis-associated CRC, 5-week-old male mice were injected 
intraperitoneally with 10 mg/kg AOM and were given 2.5% DSS in the drinking water for 7 days starting 1 week 
following the injection of AOM. Estrogen supplemented groups were received a daily intraperitoneal injection 
of E2 for 7 days, and other groups were received olive oil as a vehicle (Fig. 1). Their feces were freshly collected 
and immediately frozen in liquid nitrogen.
After genomic DNA preparation from stools, high-throughput 16S rRNA metagenome sequencing was carried 
out to determine whether differences in the gut microbiome are influenced by sex of the individual and treatment 
with E2 with or without AOM/DSS treatment in male ICR mice. The rarefaction curve of all 59 samples formed 
a plateau (Supplementary Fig. 1). Variations occurring in the gut microbial communities among different groups 
were assessed based on their generalized UniFrac distances. Results of the principal coordinates analysis (PCoA) 
showed that the bacterial communities could be distinguished based on supplementation with estrogen (Fig. 2a, 
Supplementary Fig. 2a). Except the Male_E2 samples belonging to Group 1, which were representative of the 
sex and OVX groups, no clear divergence based on the differences in sex or OVX and AOM/DSS or estrogen 
treatments was observed in samples obtained from members of Group 1 and Group 2, which is indicative of the 
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development of colon cancer in males, respectively (Fig. 2a,b, Supplementary Fig. 2a, b). PERMANOVA results 
demonstrated the beta set-significance between Group 1 (p = 0.001) and between Group 2 (p = 0.017) (Fig. 2a,b).
In Group 1, different compositions of the gut microbiota at the levels of both phylum and family taxa were 
observed (Fig. 2c,e, Supplementary Table 1, 2). At the phylum level, the abundance ratio of Cyanobacteria 
decreased significantly by estrogen supplementation in the groups involving male members (p < 0.001 based on 
the Kruskal–Wallis test; p < 0.001 for Male_Con vs. Male_E2) (Fig. 2c, Supplementary Table 1). Furthermore, 
the abundance ratio of Verrucomicrobia increased significantly in the absence of estrogen (OVX) in the groups 
with females (p = 0.054 based on the Kruskal–Wallis test; p = 0.007 for Female_con vs. Female_OVX) (Fig. 2c, 
Supplementary Table 1). Differences in the gut microbiota of members belonging to Group 2 were observed only 
at the family taxa level (Fig. 2d,f, Supplementary Table 1, 2). Furthermore, the ratio of Firmicutes to Bacteroidetes 
(F/B ratio) did not differ significantly among the members of Group 1 (Fig. 2g). Interestingly, the F/B ratio was 
significantly lower in the AOM/DSS group supplemented with E2 than that of their AOM/DSS counterparts in 
Group 2 (p = 0.061 for the Kruskal–Wallis test, p = 0.050 for Male_AOM/DSS vs Male_AOM/DSS/E2) (Fig. 2h).
The counts and abundance ratios of all operational taxonomic units (OTU) are presented in Supplementary 
Dataset 1 and 2. All p-values and q-values of the false discovery rate (FDR) obtained by comparing the results of 
Group 1 and Group 2 are shown in Supplementary Dataset 3. The result of LDA effect size obtained by compar-
ing between Group 1 and between Group 2 are shown in Supplementary Dataset 4. The microbial compositions 
at the genus levels are presented in Supplementary Fig. 3a-b. Members of the genus Alistipes were the most 
dominant organisms detected in the male and female control groups, accounting, for 26% and 24% of the total, 
respectively (Supplementary Fig. 3a). In the estrogen supplemented male (Male_E2) and estrogen eliminated 
female (Female_OVX) groups, Bacteroides was the most prominent genus identified, accounting for nearly 21% 
and 14% of the total, respectively (Supplementary Fig. 3a). In Group 2, Alistipes decreased in the Male_AOM/DSS 
group (17%) compared to Male_Con group (26%). Interestingly, the decrement of Alistipes was slightly recovered 
by estrogen supplementation (Male_AOM/DSS/E2) (20%) in Male_AOM/DSS group (Supplementary Fig. 3b).
Influence of sex and CRC following estrogen supplementation on the diversity of the gut 
microbiota. It was observed that, in Group 1, the OTU count increased significantly in both, estrogen sup-
plemented male and female control groups, compared to that observed in the male control group (p = 0.002 
for Male_Con vs. Male_E2, p = 0.008 for Male_Con vs. Female_Con) (Fig.  3a, Table  1). Similar to the OTU 
count, species richness of the gut microbiota, as indicated by the Chao 1 index, was also found to be signifi-
cantly increased in estrogen supplemented male and female control groups compared to that of the male control 
(p = 0.002 for Male_Con vs. Male_E2, p = 0.008 for Male_Con vs. Female_Con) (Fig. 3c, Table 1). However, the 
observed OTU count and Chao 1 index did not vary post ovariectomy compared to those of the female control 
group (Fig. 3a,c, Table 1). Interestingly, significant alterations in the alpha diversity indices were observed in 
the OVX group compared to that of the female control (Shannon index, p = 0.013; Simpson index, p = 0.006 for 
Female_Con vs. Female_OVX) (Fig. 3e,g, Table 1). We observed that, in Group 2, treatment of male mice with 
AOM/DSS resulted in significant alteration in the OTU count (p = 0.006 for Male_Con vs. Male_AOM/DSS) and 
values of the Chao 1 index compared to those determined in the male control group (Fig. 3b,d, Table 1). On the 
other hand, the alpha diversity indices (Shannon and Simpson) was significantly changed upon supplementation 
with E2 in the AOM/DSS male group (Shannon index, p = 0.033 and Simpson index, p = 0.028 for Male_AOM/
DSS vs Male_AOM/DSS/E2) (Fig. 3f,h, Table 1).
Figure 1.  Experimental scheme for evaluating the roles of sex and CRC following E2 on gut microbial changes. 
(a) Group 1 samples: Male_Con, Male_E2, Female_Con, and Female_OVX. Ovariectomy operation was 
performed at 4 weeks aged female mice. E2 was supplemented by intraperitoneal injection for one week at 
6 weeks aged male mice. (b) Group 2 samples: Male_Con, Male_AOM/DSS, and Male_AOM/DSS/E2. At weeks 
5, male mice were injected with AOM and were provided DSS in drinking water (2.5%) and E2 supplementation 
for 1 week at weeks 6. Fecal samples were collected at weeks 21.
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Figure 2.  Sample clustering and gut microbiota compositions at the Phylum and Family levels. Metagenome 
sequencing was performed with 16S rRNA from mouse fecal samples. Clustering of (a) Group 1 and (b) 
Group 2 mice samples by principal coordinates analysis (PCoA) at the species level. PERMANOVA test for the 
dissimilarity of bacterial population structures was performed in (a) and (b). Taxonomic composition at the (c, 
d) phylum and (e, f) family level. Microbial composition of fecal contents from (c, e) Group 1 and (d, f) Group 
2. Mann–Whitney U-test for comparison difference between independent two groups was performed in (a), (b), 
(c), (e), and (f). The difference between Group1 and between Group 2 was analysed by Kruskal–Wallis H test in 
d and g. (a), p < 0.05 between Male_Con vs. Male_E2; (b), p < 0.05 between Female_Con vs. Female_OVX; (c), 
p < 0.05 between Male_Con vs. Female_Con; (d), p < 0.05 between Group1; (e), p < 0.05 between Male_Con vs. 
Male_AOM/DSS; (f), p < 0.05 between Male_AOM/DSS vs. Male_AOM/DSS/E2; (g), p < 0.05 between Group2 
(Supplementary Table 1, 2). Firmicutes/Bacteroidetes ratio of (g) Group 1 and (h) Group 2 mice. *, p < 0.05 
for comparison between Male_AOM/DSS vs. Male_AOM/DSS/E2. Data are expressed as the mean ± SEM. 
Whiskers show the minimum and maximum values. Con, control; E2, 17β-Estradiol; OVX, ovariectomized; 
AOM, azoxymethane; DSS, dextran sulfate sodium salt.
5
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12283  | https://doi.org/10.1038/s41598-020-69112-w
www.nature.com/scientificreports/
Influence of sex and CRC due to estrogen supplementation on the composition of the gut 
microbiota. We performed the linear discriminant analysis (LDA) effect size (LEfSe) analysis to identify 
the taxonomic biomarker in the gut microbiota. According to the results of the LEfSe analysis, the proportions 
of few genera constituting the gut microbiota were higher or lower significantly in both Group 1 and Group 2 
(Fig. 4). In the male control mice, the relative abundances of opportunistic pathogens including Neglecta, Eubac-
terium_g23, Ruminococcus, and Eubacterium_g17 (p = 0.022, 0.039, 0.034, and 0.026, respectively) decreased in 
response to estrogen supplementation (Fig. 4a). In the female control mice, the relative abundances of opportun-
istic pathogens, including Eubacterium_g8 and Akkermansia (p = 0.022 and 0.007, respectively), increased while 
that of the commensal bacteria Alistipes (p = 0.013) decreased in response to the estrogen elimination (OVX) 
(Fig. 4b). In the male control mice, the relative abundance of the opportunistic pathogen Neglecta (p = 0.019) was 
higher and that of commensal bacteria including KE159571_g and KE159538_g (p = 0.041 and 0.006, respec-
tively) was lower compared to that of the female control mice (Fig. 4c). Interestingly, abundance of the com-
mensal bacteria Butyricimonas (p = 0.047) was lower in the female control mice compared to that observed in 
the males (Fig. 4c). In addition to these results, the ratio of commensal bacteria to opportunistic pathogens was 
found to be higher in Male_E2 and Female_Con groups than the Male_Con or Female_OVX groups (Fig. 4f).
The relative abundance of the opportunistic pathogen Roseburia (p = 0.009) decreased in the Male_AOM/
DSS group compared to that in the Male_Con group (Fig. 4d). Surprisingly, the abundances of commensal bac-
teria including Butyrivibrio_g1, Muribaculaceae_uc, and KE159538_g (p = 0.022, 0.045 and 0.020, respectively) 
were higher in the Male_AOM/DSS group compared to that in the Male_Con group (Fig. 4d). Additionally, the 
abundances of all of commensal bacteria including PAC000664_g and Phocea (p = 0.007 and 0.001, respectively) 
and opportunistic pathogens including Pseudoflavonifractor and Neglecta (p = 0.012 and 0.003, respectively) 
diminished in the Male_AOM/DSS/E2 group compared to that in the Male_AOM/DSS group (Fig. 4e). Unex-
pectedly, the proportion of commensal bacteria to opportunistic pathogens was higher in the Male_AOM/DSS 
group than the Male_Con or Male_AOM/DSS/E2 groups (Fig. 4f).
Enterotypes constituting the gut microbiota. To identify the properties of gut microbiota which 
could not be determined by the LEfSe analysis, Group 1 and Group 2 samples were further classified into ente-
rotypes. The most optimal number ‘k’ was determined based on the highest value of the Calinski-Harabasz (CH) 
Figure 3.  Alpha diversity of gut microbiota. (a,b) Observed OTU count, (c,d) species richness (Chao1), (e,f) 
alpha diversity (Shannon), and (g, h) alpha diversity (Simpson) of the gut microbiomes of (a,c,e, g) Group 1 and 
(b,d,f,h) Group 2 mice. Data are expressed as the mean ± SEM. Whiskers show the minimum and maximum 
values. p-values to Kruskal–Wallis test is designated on the figure; *, p < 0.05 according to Mann–Whitney U-test. 
Con, control; E2, 17β-Estradiol; OVX, ovariectomized; AOM, azoxymethane; DSS, dextran sulfate sodium salt.
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index (Supplementary Fig. 3). Samples constituting Group 1 were divided into two enterotypes because the high-
est CH value was 2 (Fig. 5a). Samples belonging to Group 2 were segregated into five enterotypes because the 
CH index was maximized when the cluster number was 5 (Fig. 5b). Enterotype 1 of Group 1 (Group 1-E1) was 
composed of 5 Male_Con., 11 Female_Con., and 7 Female_OVX samples, and it was dominated by the genus 
Alistipes (average 21%), followed by Bacteroides (12%), and PAC000186_g (11%) (Fig. 5c). Contrarily, entero-
type 2 of Group 1 (Group 1-E2) comprised only of 12 Male_E2 group and was dominated by Bacteroides (21%), 
followed by PAC001063_g (19%), and PAC000186_g (10%) (Fig. 5c). Enterotype 1 of Group 2 (Group 2-E1) 
comprised of 2 Male_Con., 6 Male_AOM/DSS, and 3 Male_AOM/DSS/E2 samples (Fig. 5d). Group 2-E1 was 
dominated by Alistipes (21%), PAC000186_g (20%), and Bacteroides (7%) (Fig. 5d). Group 2-E2 comprised of 2 
Male_Con., 2 Male_AOM/DSS, and 5 Male_AOM/DSS/E2 samples and was dominated by PAC000186_g (23%), 
Alistipes (16%), and Bacteroides (16%) (Fig. 5d). The Group 2-E3 comprised of 1 Male_Con., 1 Male_AOM/DSS, 
and 3 Male_AOM/DSS/E2 samples and was dominated by Alistipes (28%), Bacteroides (19%), and PAC000186_g 
(8%) (Fig. 5d). Group 2-E4 comprised of only 3 Male_AOM/DSS samples and was dominated by Alistipes (19%), 
KE159538_g (15%), and KE159628_g (9%) (Fig. 5d). Group 2-E5 comprised of only one Male_AOM/DSS/E2 
sample and was dominated by Akkermansia (58%), PAC000186_g (13%), and KE159628_g (9%) (Fig. 5d). We 
further analyzed the relative abundance of the dominant genera between enterotypes within Group 1 and Group 
2. In Group 1, the abundance of Alistipes (genus belonging to Bacteroidetes: Bacteroidia: Bacteroidales: Rikenel-
laceae) was significantly lower in enterotype 2 than that of enterotype 1 (p < 0.001) (Fig. 5e). The abundance 
of Bacteroides (genus belonging to Bacteroidetes: Bacteroidia: Bacteroidales: Bacteroidaceae) was significantly 
higher in enterotype 2 compared to enterotype 1 (p = 0.003) (Fig. 5g). The F/B ratio was also found to be sig-
nificantly decreased in enterotype 2 compared to enterotype 1 (p = 0.045) (Fig. 5i). In Group 2, no significant 
difference on the abundance of Alistipes was observed (Fig. 5f). The abundance of Bacteroides were higher sig-
nificantly in enterotypes 2 (p = 0.025) and 3 (p = 0.008) than that in enterotype 1 (p = 0.027 based on the Kruskal–
Wallis test) (Fig. 5h). The F/B ratios were differently regulated in each enterotype (Fig. 5j).
Functional profiles of microbial communities in mice of different sex and with CRC follow‑
ing estrogen supplementation. PICRUSt analysis was conducted to investigate the potential function 
of the gut microbiota and predict their classifications based on the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) Ortholog (KO) (www.kegg.jp/kegg/kegg1 .html). As a result, we identified differentially enriched func-
tional biomarkers in Group 1 (Table 2) and Group 2 (Table 3). In Group 1, two orthologs were found to be higher 
in both Male_E2 and Female_Con. groups compared to those of the Male_Con. or Female_OVX groups, which 
were the ABC-2 type transport system ATP-binding protein (K01990) and TonB-dependent starch-binding 
outer membrane protein SusC (K21573) (Table 2). In Group 2, 17 orthologs increased and 8 orthologs decreased 
in Male_AOM/DSS group compared with those in the Male_Con. or Male_AOM/DSS/E2 groups, respectively 
(Table 3).
Table 1.  Alpha diversity of microbiota from fecal contents. Data are presented as the medians. p-value < 0.05 
was considered to be significant and was presented as boldface. Mann–Whitney U-test for comparison 
difference between independent two groups was performed in a, b, c, e, and f. The difference between Group1 
and between Group2 was analysed by Kruskal–Wallis H test in d and g. a p-values between Male_Con vs. 
Male_E2; bp-values between Female_Con vs. Female_OVX; cp-values between Male_Con vs. Female_Con; 
dp-values between Group1; ep-values between Male_Con vs. Male_AOM/DSS; fp-values between Male_AOM/
DSS vs. Male_AOM/DSS/E2; gp-values between Group2. OTU, operational taxonomic unit; Con, control; E2, 
17β-Estradiol; OVX, ovariectomized; AOM, azoxymethane; DSS, dextran sulfate sodium salt.
Group No. of OTUs Good’s library coverage (%)
Alpha-diversity
ACE Chao1 Jackknife Shannon Simpson
Group1
Male_con. (n = 5) 448 97.50 845.92 671.14 845.70 3.69 0.09
Male_E2 (n = 12) 809 93.32 2,979.60 1835.93 2,431.81 3.64 0.11
Female_con (n = 11) 588 96.12 1,296.39 1,042.18 1,332.23 3.87 0.08
Female_ovx (n = 7) 642 95.59 1554.89 1,139.11 1,347.69 4.20 0.05
 p-valuea 0.002 0.002 0.002 0.002 0.002 0.874 0.165
 p-valueb 0.094 0.221 0.298 0.342 0.964 0.013 0.003
 p-valuec 0.008 0.020 0.100 0.008 0.062 0.307 0.863
 p-valued  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.003 0.001
Group2
Male_con (n = 5) 448 97.50 845.92 671.14 845.70 3.69 0.09
Male_AOM/DSS (n = 12) 595 95.71 1706.74 1,150.79 1,367.99 3.94 0.06
Male_AOM/DSS/E2 (n = 12) 567 95.82 1639.04 1,133.03 1,440.71 3.64 0.10
 p-valuee 0.006 0.006 0.008 0.006 0.020 0.126 0.275
 p-valuef 0.386 0.644 0.603 0.773 0.773 0.030 0.055
 p-valueg 0.020 0.018 0.026 0.017 0.060 0.070 0.152
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Figure 4.  Alterations in the abundance ratio of the gut microbiota by estrogen on sex and CRC: linear 
discriminant analysis (LDA) effect size (LEfSe) analysis. Bar plots were generated by following process. (1) an 
alpha value for the factorial Kruskal–Wallis H test between assigned taxa compared to that of the groups with 
less than 0.05, (2) an alpha value for the pairwise Wilcoxon test among the taxonomic compositions of less than 
0.05, (3) a threshold of the logarithmic LDA score for discriminative features less than 2.0, and (4) a multi-class 
analysis set as all-against-all. After this primary process, (5) overlapped bacteria selection, (6) search and classify 
the bacterial characteristics with reference to reported papers: commensal bacteria, opportunistic pathogens, 
not characterized, and (7) elimination of non-overlapped bacteria only at ‘not characterized’ bacteria. In LEfSe 
plot, all of commensal bacteria and opportunistic pathogens and only overlapped ‘not characterized’ bacteria 
are included. Bar plots at the genus level with significant differences in abundance with LEfSe analysis in (a–c) 
Group 1 (d,e) Group 2 mice. The color bars show the LDA scores of genes that enriched in indicated condition; 
(a, c, d) blue (male control mice), (a) sky blue (E2-treated male mice), (b, c) red (female control mice), (b) pink 
(ovariectomized female mice), and (d,e) purple (AOM/DSS-induced CRC). Each color on the genus name 
indicates the characteristics of each genus: yellow for commensal bacteria, orange for opportunistic pathogens, 
and green for not characterized bacteria. p-values were determined with the non-parametric factorial Kruskal–
Wallis sum-rank test. (f) The ratio of commensal bacteria to opportunistic pathogens based on the LEfSe results 
in each comparison groups. Con, control; E2, 17β-Estradiol; OVX, ovariectomized; AOM, azoxymethane; DSS, 
dextran sulfate sodium salt; N, number; NC, not calculated.
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Discussion
A direct interaction between gut microbiota, sex hormones, and the incidence of diseases has been determined 
based on the data obtained from many studies using animal models, thus suggesting that the potential differences 
in the composition of the gut microbiota between different  sex34. The aim of previous studies was to investigate 
whether tumorigenesis is reduced by estrogen supplementation in AOM/DSS-induced CRC male or OVX female 
mice  model31,35. We reported that E2 inhibited the initiation of CRC development by upregulating Nrf2 in AOM/
DSS-treated male ICR  mice31. Furthermore, AOM/DSS-induced proximal colon cancer after ovariectomy was 
reduced by E2  supplementation35. The stool used in this study was taken from the previous experimental  sets31,35 
and the current study was conducted as a secondary outcome. In this study, we investigated whether the com-
position of the gut microbiota is altered differently between sex and its correlation with the presence of estrogen 
Figure 5.  Enterotype clustering. (a) Two enterotypes (Group 1-E1, 2) of sex and OVX samples and (b) five 
enterotypes (Group 2-E1, 2, 3, 4, 5) of CRC male mice samples. The optimal cluster number was determined by 
maximizing the Calinski-Harabasz (CH) index value (Supplementary Fig. 4). The tables show the predominant 
genus in each enterotype of (c) Group 1 and (d) Group 2 mice samples. Relative abundance of (e, f) Alistipes 
and (g,h) Bacteroides, and (i,j) Firmicutes/Bacterodetes ratio of (e,g,i) Group 1 and (f,h,j) Group 2. Data are 
expressed as the mean ± SEM. Whiskers show the minimum and maximum values. p-values to Kruskal–Wallis 
test is designated on the figure; *, p < 0.05 according to Mann–Whitney U-test. Con, control; E2, 17β-Estradiol; 
OVX, ovariectomized; AOM, azoxymethane; DSS, dextran sulfate sodium salt.
Table 2.  Predicted functional biomarkers in Group 1. Data are presented as the medians. Data show the 
ortholog that increased by estrogen exposure (Male_E2 and Female_Con). LDA effect size, Linear discriminant 
analysis (LDA) effect size; FDR, false discovery rate; Con, control; E2, 17β-Estradiol; OVX, ovariectomized.
In estrogen exposure group Ortholog Definition LDA effect size p-value p-value (FDR)
Abundance ratio (mean, %)
Male_Con Male_E2 Female_Con Female_OVX
Increase K21573
TonB-dependent starch-
binding outer membrane 
protein SusC
1.6 0.024 0.039 0.140 0.340 0.227 0.219
Increase K01990 ABC-2 type transport sys-tem ATP-binding protein 1.4 0.004 0.005 0.048 0.089 0.074 0.069
9
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12283  | https://doi.org/10.1038/s41598-020-69112-w
www.nature.com/scientificreports/
and development of CRC. The results of this study demonstrated that estrogen could alter the gut microbiota in 
ICR mice, particularly in male mice treated with AOM/DSS upon decreasing the F/B ratio.
Members of Firmicutes and Bacteroidetes were the most common bacterial phyla constituting the human 
microbiome. Therefore, the F/B ratio is used as a representative index to compare between different microbial 
 communities36. Many studies have supported the idea that a low F/B ratio signifies a healthy  condition36,37. 
Additionally, a corresponding decrease in the F/B ratio was observed in patients with CRC, which could be an 
important marker for intestinal  dysbiosis38,39. A higher F/B ratio at a BMI of 33 was observed in men compared 
to that in  women40. Contrarily, a significantly lower F/B ratio was observed in men than that in women in the 
group with BMI > 3340. Furthermore, evidence from many studies has suggested that the F/B ratio was higher 
in normal range women than in men. Varied meanings of the F/B ratio between different investigations have 
been reported. We have previously reported that colitis associated colon carcinogenesis in AOM/DSS-treated 
mice model was induced more severely in male mice than female by way of the inflammatory mediators such as 
IL-1β and  MPO30. Furthermore, we found that E2 inhibited the initiation of CRC by up-regulating nuclear factor 
erythroid 2-related factor 2 (Nrf2), a transcriptional factor-related pathways in the AOM/DSS-treated male ICR 
 mice31. The stool from the previous experimental  sets31,35 was taken and the current study was conducted. The 
target protein expression such as IL-1β and MPO was strongly affected by estrogen in acute treatment condition. 
However, the modest changes on gut microorganisms observed in this study may be originated from too short 
of intervention, which is a limitation of this study. In the current study, no significant difference in the F/B ratio 
In AOM/DSS group Ortholog Definition LDA effect size p-value p-value (FDR)
Abundance ratio (mean, %)
Male_Con Male_AOM/DSS Male_AOM/DSS/E2
Increase K06356 Phosphatase RapG regulator 2.1 0.041 0.048 0.175 0.201 0.125
Increase K03200 Type IV secretion system protein VirB5 1.9 0.013 0.013 0.066 0.087 0.050
Increase K02160 acetyl-CoA carboxylase biotin carboxyl carrier protein 1.8 0.038 0.044 0.059 0.078 0.047
Increase K07655 Two-component system, OmpR family, sensor histidine kinase PrrB 1.8 0.036 0.042 0.040 0.054 0.028
Increase K18298 Membrane fusion protein, multid-rug efflux system 1.7 0.022 0.024 0.074 0.091 0.063
Increase K02315 DNA replication protein DnaC 1.6 0.022 0.024 0.031 0.050 0.042
Increase K07862 Serine/threonine transporter 1.5 0.039 0.046 0.053 0.059 0.044
Increase K07447 Putative holliday junction resolvase 1.5 0.007 0.007 0.022 0.037 0.031
Increase K05630 NEDD4-like E3 ubiquitin-protein ligase WWP2 1.5 0.019 0.020 0.055 0.060 0.045
Increase K08095 Cutinase 1.4 0.022 0.024 0.021 0.029 0.016
Increase K18037 Tyrosine-protein phosphatase non-receptor type 4 1.4 0.030 0.033 0.017 0.022 0.013
Increase K07676 Two-component system, NarL fam-ily, sensor histidine kinase RcsD 1.3 0.012 0.013 0.033 0.037 0.021
Increase K13212 RNA-binding protein Luc7-like 2 1.3 0.024 0.026 0.029 0.033 0.021
Increase K16288 Dual serine/threonine and tyrosine protein kinase 1.3 0.022 0.025 0.015 0.021 0.011
Increase K07440 Cholesterol 24-hydroxylase 1.3 0.025 0.027 0.054 0.058 0.038
Increase K07583 tRNA pseudouridine synthase 10 1.3 0.037 0.043 0.021 0.025 0.017
Increase K07640
Two-component system, OmpR 
family, sensor histidine kinase 
CpxA
1.3 0.035 0.040 0.016 0.020 0.012
Decrease K06145
LacI family transcriptional regula-
tor, gluconate utilization system 
Gnt-I transcriptional repressor
1.5 0.006 0.007 0.044 0.027 0.033
Decrease K00338 NADH-quinone oxidoreductase subunit I 1.5 0.028 0.032 0.041 0.029 0.035
Decrease K07028 Uncharacterized protein 1.4 0.016 0.017 0.030 0.018 0.022
Decrease K07449 Similar to archaeal holliday junc-tion resolvase and Mrr protein 1.3 0.005 0.005 0.037 0.018 0.022
Decrease K01751 diaminopropionate ammonia-lyase 1.3 0.025 0.028 0.049 0.040 0.044
Decrease K01277 dipeptidyl-peptidase III 1.3 0.033 0.037 0.053 0.049 0.058
Decrease K01218 mannan endo-1,4-beta-mannosi-dase 1.3 0.005 0.005 0.068 0.054 0.058
Decrease K01225 cellulose 1,4-beta-cellobiosidase 1.3 0.007 0.007 0.017 0.006 0.010
Table 3.  Predicted functional biomarkers in Group 2. Data are presented as the medians. Data show the 
ortholog that increased and decreased in AOM/DSS group (Male_AOM/DSS). LDA effect size, Linear 
discriminant analysis (LDA) effect size; FDR, false discovery rate; Con, control; AOM, azoxymethane; DSS, 
dextran sulfate sodium salt; E2, 17β-Estradiol.
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was observed in the Group 1 samples based on the differences in sex and the presence or absence of estrogen. 
Interestingly, the F/B ratio was significantly decreased upon estrogen supplementation in the male AOM/DSS 
group relative to Male_AOM/DSS group. These results have supported that estrogen treatment in CRC models 
could decrease intestinal dysbiosis by decreasing the F/B ratio.
Different from gender which is related to the social and cultural role of human, sex is biologically determined 
based on the physiology of the reproductive systems and functions derived from the types of chromosomes or 
hormones. The terms of ‘male’ and ‘female’ are used to describe the sex of human participants or other sex-related 
 factors41. Despite differences in sex, most preclinical studies have adopted the use of male animals, and a few 
have not mentioned the sex of the animal  used42. In the present study, we used both male and female mice and 
investigated the impact of sex hormones, particularly, the female sex hormone ‘estrogen’, on changes in the com-
position of the gut microbiota. Furthermore, the female mice were subjected to an OVX operation to determine 
the effect of endogenous estrogen. The results derived from these experiments signify the importance of our 
research. According to an animal study reported by Org et al., independent analysis of the gut microbiota using 
89 different inbred strains of mice was conducted and clear differences in the composition of the gut microbiota 
and diversity between the sex within each strain was  observed25. Particularly, obvious differences in the results 
between sex were observed in the C57BL/6J and C3H/HeJ  strains25. In the total animal experimental cohort, 
the members of the phyla Actinobacteria and Tenericutes were more abundant in the male mice than in female 
 mice25. In our present study, abundance of the phyla Tenericutes was not correlated with sex. However, its pro-
portion was higher in male mice than in male mice supplemented with E2. Furthermore, at the species level, the 
abundance of Bacteroides thetaiotaomicron was found to be increased in male mice relative to those supplemented 
with E2, which was similar to the results observed in a previous study conducted in 2008 involving Chinese 
family  members43. In another large cohort study, it was determined that females in the Netherlands had a higher 
proportion of Akkermansia muciniphila even after correcting all potential risk factors such as diet, lifestyle, and 
medication for the normal  health27. In a Japanese study, significantly higher levels of members belonging to the 
genus Akkermansia were observed in the females than in  males44 and higher levels of Akkermansia muciniphila 
were identified in C57BL/6 background female relative to male  mice45. Additionally, an increased abundance 
of Clostridium bolteae was observed in humans after bilateral  ovariectomy27. Unlike the compositional change 
of the gut microbiota in humans, which is dependent on sex and the presence of estrogen, in the present study, 
the abundance of Akkermansia muciniphila did not increase in female mice compared to that of the male mice. 
Contrarily, the abundance of Akkermansia muciniphila was found to be increased in OVX female mice compared 
with that of the intact female mice, which was consistent with the results presented in a previous report by Choi 
et al.46 Akkermansia muciniphila is a mucin-degrading bacteria that can convert mucin to short-chain fatty 
 acids47. In addition to its role as a commensal bacteria, it has been reported to be involved in pro-inflammatory 
pathways and the activation of chemotaxis and the complement  cascade48. Furthermore, it has been reported 
that the organism had exacerbated an intestinal inflammation in mice infected with Salmonella typhimurium by 
disturbing host mucus  homeostasis49. Although no change in abundance of Akkermansia muciniphila based on 
sex was observed, its increase in the OVX female group suggested that mucin homeostasis was disrupted due 
to estrogen removal.
The etiology of CRC development has been investigated in human patients and experimental animal models. 
It was concluded that the genetic (e.g.  diabetes50 and  obesity51) and dietary risk factors (e.g. high fat  diet52 and 
processed and red  meat53) are involved in its development. However, according to a recent review article, it has 
been suggested that the intestinal microbial community may also be an important contributing factor in the 
initiation and development of CRC 54. The intestinal microflora of DSS-treated C57BL/6 background mice has 
been characterized by a loss in microbial diversity and changes taking place in the bacterial composition, which 
included a decrease in the number of bacteria from the Lactobacillus group and an increase Enterobacteriaceae, 
Akkermansia and Desulfovibrio16. Furthermore, it is well known that Fusobacterium nucleatum is highly associ-
ated with CRC  development55. In the present study, Fusobacterium nucleatum was not identified in the experi-
mental CRC group. Contrary to the results generated in the study involving C57BL/6  mice16, at the species level, 
a higher abundance of Lactobacillus reuteri was observed in AOM/DSS-induced CRC mice compared to that 
present in intact male mice. Contrarily, a higher abundance of the species Lactobacillus murinus was observed 
in AOM/DSS-treated male mice supplemented with E2 compared with that of the AOM/DSS-treated male mice. 
In the present study, Lactobacillus reuteri is a well-studied probiotic bacterium capable of colonizing in the bod-
ies of many  mammals56. In humans, the species has been detected from different sites of the body, including 
the gastrointestinal tract, urinary tract, skin, and breast  milk56. Lactobacillus reuteri can produce antimicrobial 
compounds such as organic acids, ethanol, and reuterin. Due to its antimicrobial activity, Lactobacillus reuteri is 
able to inhibit the colonization of pathogenic microbes and remodel the composition of commensal microbiota 
in the  host56. Our data suggest that Lactobacillus reuteri and Lactobacillus murinus may differently act during 
CRC progression.
It would have been insightful if we could simultaneously verify the effects of testosterone and estrogen, 
which is a limitation of this study. Testosterone, which is the primary male sex hormone, plays a pivotal role in 
the development of male reproductive organs such as the testes and prostate and promotes the development of 
secondary sexual characteristics such as muscle strength and bone mass. Additionally, testosterone is involved 
in the health and wellbeing of the  individual57. Therefore, to support the limitation of this study, we are conduct-
ing experiments in which animals are subjected to orchiectomy. To confirm the impact of testosterone on the 
gut microbiota, which consequently is impacted by differences in sex and CRC development, a study involv-
ing orchiectomy study is needed. Unfortunately, it was difficult to find models with consistent gut microbiota 
among sex and affected by sex hormones. However, few were available, which could be identified based on the 
functional profiles of microbial communities in mice of different sex and in which, development of CRC was 
impacted due to the presence or absence of estrogen. Currently, we are conducting experiments to analyze gut 
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microbiota according to sex differences in another strain, C57BL/6 mice. We have not verified sex differences in 
gut microorganisms in the AOM/DSS group, which is a limitation of this study. This is also currently under study 
in the C57BL/6 strain. In addition, it was regrettable that there was no consideration for progesterone therapy 
and that the estrogen supplementation group was not added after ovariectomy.
In conclusion, we can state that estrogen altered the gut microbiota in ICR mice, particularly in males treated 
with AOM/DSS, by decreasing the F/B ratio. This suggests another possibility that estrogen could cause changes 
in the gut microbiota, thus reducing the risk of developing CRC.
Methods
Animals and experimental design. Three and four-week-old female and male ICR mice (Orient Co., 
Ltd., Seoul, Korea) were housed in cages at 23  °C and subjected to a 12/12-h light/dark cycle under specific 
pathogen-free conditions. The experimental design is presented in Fig. 1. The experiments were conducted on 
models distinguished into two categories, which were as follows: (1) sex and OVX as Group 1, and (2) colon 
cancer in males as Group 2. Group 1 was further divided into 4 subgroups, which were as follows: (1) normal 
male control mice (n = 5), (2) E2 supplemented male mice (n = 12), (3) normal female control mice (n = 11), and 
(4) ovariectomized (OVX) female mice (n = 7) (Fig. 1a). Similarly, group 2 was divided into 3 subgroups, which 
were as follows: (1) normal male control mice (n = 5), (2) AOM/DSS-treated male mice (n = 12), and (3) AOM/
DSS-treated male mice supplemented with E2 (n = 12) (Fig. 1b).
After 1 week of acclimatization, the 4-week-old female mice were subjected to ovariectomy in order to create 
an animal model that could mimic the physiology during menopause through the elimination of endogenous 
female sex hormones. The normal female control mice were subjected to a sham operation. E2 (10 mg/kg; Sigma-
Aldrich, E8876) was dissolved in olive oil, and Male_E2 mice group was received a daily intraperitoneal injection 
of E2 for 7 days. Except Male_E2 group, others were injected olive oil as a vehicle.
To induce colitis-associated CRC, 5-week-old male mice were injected intraperitoneally with AOM (10 mg/
kg; Sigma-Aldrich, St. Louis, MO, USA) and 2.5% (w/v) DSS (MP Biomedicals, Aurora, OH, USA) was adminis-
tered through their drinking water for 7 days starting 1 week following the injection of  AOM58. E2-treated mice 
received an intraperitoneal injection of E2 dissolved in olive oil daily for 7 days. The injections were administered 
at the time of DSS consumption. Their feces were freshly collected from 59 individual male and female mice in 
fifteen separate cages. All fecal samples were immediately frozen in liquid nitrogen and stored at − 80 °C. The ani-
mals were euthanized by  CO2 asphyxiation (Fig. 1). The stool from the previous experimental  sets31,35 was taken 
and the current study was conducted. Mice were randomly divided from shipment group. All mice were housed 
in the same room in filter top cages, with three to five mice per cage. Mice were marked so that individual mice 
could be followed for the duration of the experiments. All animal experimental procedures were approved by 
the Institutional Animal Care and Use Committee (IACUC) of the Seoul National University Bundang Hospital 
(BA1310-139/091-01). The procedures were carried out in accordance with the ARRIVE (Animals in Research: 
Reporting of in Vivo Experiments) guideline.
DNA extraction and metagenome sequencing of the 16S rRNA gene. Genomic DNA was 
extracted from the frozen fecal samples using a QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA, United 
States) according to the manufacturer’s recommendations. PCR amplification was carried out using the primers 
targeting the V3 to V4 regions of the 16S rRNA gene of the extracted DNA to conduct metagenome sequenc-
ing, and were as  follows59: 341F (5′-TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG CCT ACGGGNGGC 
WGC AG-3′) and 805R (5′-GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTACHVGGG TAT 
CTA ATC C-3′). Next procedures were performed as described  previously59. Briefly, the identity of the PCR prod-
ucts was confirmed using electrophoresis. They were purified using a QIAquick PCR Purification Kit (Qiagen, 
Valencia, CA, USA). The purified PCR products were tagged with Illumina indices and adapters from a Nex-
tera XT Index Kit (Illumina, San Diego, CA, USA). Short DNA fragments were eliminated using a FavorPrep 
Gel/PCR Purification Kit (Favorgen, Taiwan). The PCR amplicons were quantified using a Quant-iT PicoGreen 
dsDNA Assay Kit (Thermo Fisher Scientific, Wilmington, DE, USA). After pooling the DNA (300 ng per sam-
ple), the PCR products were purified using a FavorPrep Gel/PCR Purification Kit (Favorgen, Taiwan). The qual-
ity assessment for confirming the integrity and product size of the DNA was conducted using a Bioanalyzer 
2,100 (Agilent, Palo Alto, CA, USA) using a DNA 7,500 chip at ChunLab, Inc. (Seoul, South Korea). Metage-
nome sequencing was carried out using the Illumina MiSeq platform at ChunLab, Inc. (Seoul, South Korea).
The raw reads were processed by first checking the quality wherein low quality (< Q25) reads were filtered 
out using a Trimmomatic 0.3260. The paired-end sequence data was merged using  PANDAseq61. The primer 
sequences were then trimmed using an inhouse program of the ChunLab, Inc. (Seoul, South Korea) with a 
similarity cut off of 0.8. Non-specific amplicons, which did not encode 16S rRNA, were identified by using the 
HMMER program hmmsearch based on the 16S rRNA  profiles62. The sequences were denoised using a DUDE-
Seq63, and non-redundant reads were extracted through UCLUST-clustering64. The EzBioCloud database was 
utilized for performing the taxonomic assignment using USEARCH (8.1.1861_i86linux32)64 followed by more 
precise pairwise  alignment65.  UCHIME66 and the non-chimeric 16S rRNA database from EzBioCloud were used 
to detect the chimaeras for reads containing a best hit similarity rate of less than 97%. The sequence data was 
then clustered using CD-HIT67 and  UCLUST64.
Rarefaction for the obtained OTUs was calculated using the BIOiPLUG (ChunLab, Inc.). The reads were 
normalized to 7,525 to perform the analyses. The microbial diversity (Observed OTU count, Chao1, Shannon, 
and Simpson indices) was examined using BIOiPLUG. To visualize differences in the samples, PCoA was assessed 
using generalized UniFrac. The clustering of samples was explained based on the values of the principal coordi-
nate (PC). Additionally, an Unweighted Pair Group Method with Arithmetic mean (UPGMA) tree was created 
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using BIOiPLUG (ChunLab, Inc.). The beta diversity distances were calculated using generalized UniFrac. The 
significance of the separation between the groups was calculated by permutational multivariate analysis of vari-
ance (PERMANOVA) test. Taxonomic summary bar charts were created to determine the OTU abundance ratio 
(%) at the phylum and family levels using GraphPad Prism (version 5.01). The enterotype classification of the 
gut microbiota at the genus level was calculated using the R package “clusterSim”. The optimal cluster number 
was determined by maximizing the value of the Calinski-Harabasz (CH)  index68.
Biomarker discovery through the linear discriminant analysis (LDA) effect size (LEfSe). Based 
on the relative taxonomic abundances, the taxonomic biomarker discovery and related statistical significance 
were assessed by the LEfSe  method69. The criteria for conducting the LEfSe analysis were as follows: (1) an alpha 
value for the factorial Kruskal–Wallis H test between assigned taxa compared to that of the groups with less than 
0.05, (2) an alpha value for the pairwise Wilcoxon test among the taxonomic compositions of less than 0.05, (3) 
a threshold of the logarithmic LDA score for discriminative features less than 2.0, and (4) a multi-class analysis 
set as all-against-all. After this process, we went further to simplify the LEfSe plot. (5) overlapped bacteria selec-
tion, (6) search and classify the bacterial characteristics with reference to reported papers: commensal bacteria, 
opportunistic pathogens, not characterized, and (7) elimination of non-overlapped bacteria only at ‘not charac-
terized’ bacteria. In LEfSe plot, all of commensal bacteria and opportunistic pathogens and only overlapped ‘not 
characterized’ bacteria are included.
To predict the functional biomarker profiles of bacterial communities, we conducted their phylogenetic 
investigations through reconstructing of unobserved states (PICRUSt)70 based on the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database (www.kegg.jp/kegg/kegg1 .html). Discovery of the functional biomarker 
and associated statistical significance were assessed based on the LEfSe.
Statistical analysis. Statistical calculations except those of the pyrosequencing data were performed using 
PASW Statistics version 18.0.0 (SPSS Inc., 2009, Chicago, IL, USA). The groups were compared based on the 
results of the Kruskal–Wallis H test. Then, the two groups were compared using the Mann–Whitney U test 
(also known as the Wilcoxon rank sum test), and the p-value < 0.05 was considered to be significant. For the 
adjustment of multiple comparisons, corrected q-values of the false discovery rate (FDR) were calculated for 
significance less than 5%.
Data availability
The raw unprocessed gene datasets of 16S rRNA, which were generated during the current study, are available 
with the NCBI Sequence Read Archive (SRA Accession Number PRJNA590320), https ://www.ncbi.nlm.nih.
gov/sra/PRJNA 59032 0. The processed data generated and analyzed during this study has been included in this 
published article under Supplementary Dataset files.
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